Patents by Inventor Faye M. Johnson

Faye M. Johnson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF SQUAMOUS CELL CARCINOMA
    Publication number: 20210299133
    Abstract: The present invention relates to a method of predicting the vulnerability of a squamous cell carcinoma (SCC) to inhibition by a P13K inhibitor, preferably by a P13K/mTOR inhibitor, including the selection of the patient predicted to benefit from therapeutic administration with the P13K inhibitor, preferably of the P13K/mTOR inhibitor. Moreover, the present invention relates to a method of treating a squamous cell carcinoma (SCC) of a mammal, preferably a human patient, comprising administering a therapeutically effective amount of a P13K inhibitor, preferably a therapeutically effective amount of a P13K/mTOR inhibitor to said mammal, preferably said human patient. Furthermore, the present invention relates to pharmaceutical compositions and kits associated with the inventive methods.
    Type: Application
    Filed: August 7, 2019
    Publication date: September 30, 2021
    Inventors: Melanie ROLLI, Debora SCHMITZ-ROHMER, Doriano FABBRO, Mitchell FREDERICK, Faye M. JOHNSON
  • Biomarker Identifying the Reactivation of STAT3 After Src Inhibition
    Publication number: 20130012519
    Abstract: A method of identifying cancer or an associated disorder comprising identifying and quantifying STAT3 occurring in a biological sample taken from a subject after administering a SFK inhibitor to said subject.
    Type: Application
    Filed: September 14, 2012
    Publication date: January 10, 2013
    Applicants: BRISTOL-MYERS SQUIBB COMPANY, BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Faye M. Johnson, Nicholas J. Donato, Francis Y. Lee
  • BIOMAKER IDENTIFYING THE REACTIVATION OF STAT3 AFTER SRC INHIBITION
    Publication number: 20100173426
    Abstract: A method of identifying cancer or an associated disorder comprising identifying and quantifying STAT3 occurring in a biological sample taken from a subject after administering a SFK inhibitor to said subject.
    Type: Application
    Filed: December 18, 2007
    Publication date: July 8, 2010
    Inventors: Faye M. Johnson, Nicholas J. Donato, Francis Y. Lee